Janux Therapeutics Inc (JANX)
47.11
-0.40
(-0.84%)
USD |
NASDAQ |
May 17, 16:00
47.11
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Free Cash Flow: -53.26M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -53.26M |
| December 31, 2023 | -52.42M |
| September 30, 2023 | -55.98M |
| June 30, 2023 | -59.73M |
| March 31, 2023 | -51.07M |
| December 31, 2022 | -49.37M |
| September 30, 2022 | -47.05M |
| Date | Value |
|---|---|
| June 30, 2022 | -37.05M |
| March 31, 2022 | -36.36M |
| December 31, 2021 | -18.46M |
| September 30, 2021 | -8.124M |
| June 30, 2021 | -3.353M |
| March 31, 2021 | 2.07M |
| December 31, 2020 | -4.369M |
Free Cash Flow Range, Past 5 Years
-59.73M
Minimum
Jun 2023
2.07M
Maximum
Mar 2021
-33.90M
Average
-42.05M
Median
Free Cash Flow Benchmarks
| Viking Therapeutics Inc | -54.87M |
| Equillium Inc | -22.66M |
| Minerva Neurosciences Inc | -20.76M |
| Arvinas Inc | -356.00M |
| Calidi Biotherapeutics Inc | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.84M |
| Cash from Investing (Quarterly) | -113.74M |
| Cash from Financing (Quarterly) | 322.17M |
| Free Cash Flow Per Share (Quarterly) | -0.3065 |
| Free Cash Flow to Equity (Quarterly) | -15.03M |
| Free Cash Flow Yield | -2.47% |